Cite

HARVARD Citation

    Skinner, K. et al. (2020). Real‐world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer. Breast journal. 26 (2), pp. 112-119. [Online]. 
  
Back to record